Who can safely evade a magnetic resonance imaging fusion-targeted biopsy (MRIFTB) for prostate imaging reporting and data system (PI-RADS) 3 lesion?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://link.springer.com/content/pdf/10.1007/s00345-020-03352-3.pdf
Reference20 articles.
1. Jhaveri FM, Klein EA, Kupelian PA, Zippe C, Levin HS (1999) Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol 17:3167–3172
2. Derweesh IH, Kupelian PA, Zippe C, Levin HS, Brainard J, Magi-Galluzzi C et al (2004) Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol 22:300–306
3. Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB et al (2014) Overdiagnosis and overtreatment of prostate cancer. Eur Urol 65:1046–1055
4. Ahmed HU, Bosaily AE-S, Brown LC, Gabe R, Kaplan R, Parmar MK et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815–822
5. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. New Eng J Med 378:1767–1777
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Magnetic Resonance Imaging, Clinical, and Biopsy Findings in Suspected Prostate Cancer;JAMA Network Open;2024-03-29
2. Infectious Disease Physician Availability and Postgraduate Antimicrobial Stewardship Education in Japan;JAMA Network Open;2024-03-29
3. Management Strategy for Prostate Imaging Reporting and Data System Category 3 Lesions;Current Urology Reports;2023-11-08
4. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial;European Urology;2023-10
5. Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRI;Urologic Oncology: Seminars and Original Investigations;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3